FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/03/031838 [Registered on: 09/03/2021] Trial Registered Prospectively
Last Modified On: 09/01/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effectiveness of physical therapy intervention on primary painful menstrual cycle. 
Scientific Title of Study   Effectiveness of Non-Invasive Intervention on Anterior Uterocervical Angle in Primary Dysmenorrhea Patients: A Randomized Controlled Trial. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
U111112653764  UTN 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vandana Esht 
Designation  Associate Professor 
Affiliation  MMIPR 
Address  Maharishi Markandeshwar (Deemed to be university), Maharishi Markandeshwar Institute of Physiotherapy and Rehablitation (MMIPR), room no- 37, Ambala, Haryana

Ambala
HARYANA
133203
India 
Phone  8059930235  
Fax    
Email  vandanaesht@mmumullana.org  
 
Details of Contact Person
Scientific Query
 
Name  Sunita Sharma 
Designation  Assitant Professor 
Affiliation  MMIPR 
Address  Maharishi Markandeshwar (Deemed to be university), Maharishi Markandeshwar Institute of Physiotherapy and Rehablitation (MMIPR), Ambala, Haryana

Ambala
HARYANA
133203
India 
Phone  9467633734  
Fax    
Email  drsunita.sharma@mmumullana.org  
 
Details of Contact Person
Public Query
 
Name  Sunita Sharma 
Designation  Assitant Professor 
Affiliation  MMIPR 
Address  Maharishi Markandeshwar (Deemed to be university), Maharishi Markandeshwar Institute of Physiotherapy and Rehablitation (MMIPR), Ambala, Haryana

Ambala
HARYANA
133203
India 
Phone  9467633734  
Fax    
Email  drsunita.sharma@mmumullana.org  
 
Source of Monetary or Material Support  
Nil 
 
Primary Sponsor  
Name  Maharishi Markandeshwar Deemed to be university 
Address  Maharishi Markandeshwar (Deemed to be university), Maharishi Markandeshwar Institute of Physiotherapy and Rehablitation (MMIPR), Ambala, Haryana 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Sunita Sharma  Maharishi Markandeshwar (Deemed to be university), Maharishi Markandeshwar Institute of Physiotherapy and Rehablitation (MMIPR), Ambala, Haryana 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sunita Sharma  Maharishi Markandeshwar Hospital  Maharishi Markandeshwar hospital outpatient department, Musculoskeletal Physiotherapy research lab, room no-B 30, Mullana, Ambala, Haryana
Ambala
HARYANA 
9467633734

drsunita.sharma@mmumullana.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MAHARISHI MARKANDESHWAR (DEEMED TO BE UNIVERSITY), INSTITUTIONAL ETHICS COMMITTEE, MULLANA, AMBALA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M60-M63||Disorders of muscles,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional therapy including (deep breathing exercise, music therapy, core strengthening, stretching exercise)  A conventional intervention will be provided for 4 months, 2days before the date of menstruation with1week of protocol every month. 
Intervention  Manual therapy including (uterus manipulation, cranial electric stimulation, deep breathing, music therapy, stretching of hamstring muscle, quadriceps, quadratus lumborum muscle, core strengthening)   4 months, starting 2 days before the expected date of menstruation, and 1 week of protocol will be provided every month along with a home exercise program 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  I. Medical, Physiotherapy and Nursing female students of regional medical university.
II. Age group 18-35 years
III. Willing Participants
IV. Participants were diagnosed with primary dysmenorrhea according to pathos-physiology of dysmenorrhea.
 
 
ExclusionCriteria 
Details  I. Hypertension, Diabetes, any other chronic disease
II. Secondary Dysmenorrhea.
III. Any Neurological and Cardiological disorder.
IV. Irregular periods
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Diagnostic ultrasound   it will be measured prior and after intervention 
 
Secondary Outcome  
Outcome  TimePoints 
International physical activity questionnaire, Depression anxiety scale (DASS21), and Visual Analogue scale (VAS).  it will be measured prior and after intervention 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "46"
Final Enrollment numbers achieved (India)="46" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/03/2021 
Date of Study Completion (India) 24/11/2023 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 24/11/2023 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Background: Dysmenorrhea is a common problem in females which causes pain in the lower abdomen and lower back, cramp in thighs and give rise to stress, anxiety, and depression. So in primary dysmenorrhea girls lose their quality of life.

 

Purpose: The purpose of this study is to compare the effect of quality of life and the improvement of pain along with evidence based tool (diagnostic ultrasound).

 

Material and Methods: Participants of primary dysmenorrhea of age between 18-35 years will be recruited based on selection criteria by the purposive sampling method. All participants will be randomly allocated into 2 groups, group A (experimental group 1) and group B(Comparison group 2)  All participants will be assessed at baseline with outcome measures of quality of life, improvement of pain, vas, depression scale, and diagnostic ultrasound. 

Duration of interventions would be 25 days during menstruation cycle treatment shall be provided 2 days before and during the menstrual cycle so that is a 1-week protocol 2days before the menstrual cycle and 5days during menstrual cycle.

 
Close